CVS Health Allergy Relief D Tablets Recalled for Failed Dissolution
CVS Health Allergy Relief D Extended Release Tablets are being recalled because they failed to meet dissolution specifications. The recall affects 41,784 boxes distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses or injuries. Failed dissolution specifications constitute a labeling/manufacturing defect with potential efficacy concerns but no documented harm, meeting the criteria for Moderate severity.
Plain-English summary
CVS Health Allergy Relief D, containing Fexofenadine HCl 60mg (antihistamine) and Pseudoephedrine HCl 120mg (nasal decongestant), is being recalled due to failed dissolution specifications. The product is supplied in two configurations: 20-count boxes (UPC 050428436189) and 30-count boxes (UPC 050428290538).
The recall affects approximately 41,784 boxes that were distributed nationwide in the USA. The affected lot numbers are: for 20-count boxes, AC2000968A and AC2000968F (expiration 8/31/2022); for 30-count boxes, 79C002624B (expiration 4/30/2022), AC2103330G, and AC2103330H (expiration 1/31/2023). The product was manufactured by Dr. Reddy's Laboratories, Inc. in India and distributed by CVS Pharmacy Inc.
Consumers who have purchased this product should stop using it. Those with questions or concerns should contact their healthcare provider or pharmacist.
The recalled product
- Product
- CVS Health, Allergy Relief D, Fexofenadine HCl 60mg/Antihistamine Pseudoephedrine HCl 120mg/Nasal Decongestant, a) 20 Extended Release Tablets per box, UPC 050428436189, b) 30 Extended Release Tablets per box, UPC 050428290538, Distributed by CVS Pharmacy Inc., One CVS Drive, Wo
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Hazard
- dissolution-failure
- efficacy-concern
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot #s: a) (20-count): AC2000968A
- AC2000968F
- Exp. 8/31/2022. b) (30-count): 79C002624B
- Exp. 4/30/2022
- AC2103330G
- AC2103330H
- Exp. 1/31/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateMeijer Earwax Removal Kit Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22